Occam Recruits Sales and Operations Leader to the Board of Geron
In March 2019, Occam Global recruited Dawn C. Bir to the Board of Geron Corporation, a public commercial-stage oncology biotech. Bir also serves on the Board of Soleno Therapeutics and was the Chief Commercial Officer at Reata Pharmaceuticals from September 2016 until Biogen’s $7.3B acquisition of Reata in 2023. Prior to her time at Reata, she held several key leadership positions at Pharmacyclics, McKesson, Genentech, and Bristol-Myers Squibb, demonstrating a strong track record in sales, operations, and team development across various therapeutic areas.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.